About us
CEO


Ph.D. CEO
KWANG-SUNG AHN
Disease prognostic Minner
CEO of PDXen Biosystems Co.
- MAJOR IN Oncology Biology and Oncology Genetics
- Ph.D. (University of Houston)
- Post-doc (UCLA)
- Senior Researcher (Samsung Biomedical Research Institute, SBRI)
- Research Professor of Pathology, Korea University College of Medicine
- Research Professor, Cancer Research Institute, Seoul National University College of Medicine
Organization
History
2019
01 Registration of Animal laboratory Facilities
2018
11 Establishment of Seoul Branch
11 Registration of PDXen Institutional Review Board (IRB)
07 Investment attraction from Individual Investors
04 Selected as Korea Engineering Service Provider (K-ESP)
01 Established of Pangyo Branch in Pangyo 2nd Techno Valley Enterprise Support Hub Center
2017
11 Registered as a Research Institute of ETRI (No. 500)
10 Moved the head office to ETRI Convergence Technology Commercialization Center
10 Investment attraction from ETRI and ETRI Holdings Co
09 Certification of Research and Development Services
2015
09 Moved the head office to Venture Town of Korea Institute of Science and Technology
2014
01 Establishment of Research Institute (Functional Genome Institute)
2013
10 Certified as a Venture Company
09 Establishment of PDXen Biosystems Co.